Evidence map›Paper›PMID 23439483›Full record

ArticleMolecular psychiatry2014

Neurodevelopmental and neuropsychiatric disorders represent an interconnected molecular system.

A S Cristino, S M Williams, Z Hawi, J-Y An, M A Bellgrove, C E Schwartz, L da F Costa, C Claudianos

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Molecular psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 120 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
120citing papers in PubMed, 5 pooled it
10.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

120 citing papers in PubMed, 5 syntheses or guidelines pooled it, 237 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Review
  9. A complex network perspective on brain disease.Biological reviews of the Cambridge Philosophical Society · 2026
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. The relationship between neurodevelopmental disorders (NDDs) and NLRP3 inflammasome.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  17. Article
  18. Article
  19. Connectome-based symptom mapping andmedRxiv : the preprint server for health sciences · 2024
    Article
  20. Review

60 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

A S CristinoQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
S M WilliamsQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
Z Hawi1] Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia [2] School of Psychology and Psychiatry, Monash University, Melbourne, VIC, Australia.
J-Y AnQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
M A Bellgrove1] Queensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia [2] School of Psychology and Psychiatry, Monash University, Melbourne, VIC, Australia.
C E SchwartzGreenwood Genetic Center, Greenwood, SC, USA.
L da F CostaInstituto de Física de São Carlos, Universidade de São Paulo, São Paulo, Brazil.
C ClaudianosQueensland Brain Institute, The University of Queensland, Brisbane, QLD, Australia.
University of Queensland · AUGreenwood Genetic Center · USMonash University · AUUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many putative genetic factors that confer risk to neurodevelopmental disorders such as autism spectrum disorders (ASDs) and X-linked intellectual disability (XLID), and to neuropsychiatric disorders including attention deficit hyperactivity disorder (ADHD) and schizophrenia (SZ) have been identified in individuals from diverse human populations. Although there is significant aetiological heterogeneity within and between these conditions, recent data show that genetic factors contribute to their comorbidity. Many studies have identified candidate gene associations for these mental health disorders, albeit this is often done in a piecemeal fashion with little regard to the inherent molecular complexity. Here, we sought to abstract relationships from our knowledge of systems level biology to help understand the unique and common genetic drivers of these conditions. We undertook a global and systematic approach to build and integrate available data in gene networks associated with ASDs, XLID, ADHD and SZ. Complex network concepts and computational methods were used to investigate whether candidate genes associated with these conditions were related through mechanisms of gene regulation, functional protein-protein interactions, transcription factor (TF) and microRNA (miRNA) binding sites. Although our analyses show that genetic variations associated with the four disorders can occur in the same molecular pathways and functional domains, including synaptic transmission, there are patterns of variation that define significant differences between disorders. Of particular interest is DNA variations located in intergenic regions that comprise regulatory sites for TFs or miRNA. Our approach provides a hypothetical framework, which will help discovery and analysis of candidate genes associated with neurodevelopmental and neuropsychiatric disorders.

Indexed as

Models, GeneticAttention Deficit Disorder with HyperactivityChild Development Disorders, PervasiveDatabases, GeneticGene Expression RegulationGenetic Association StudiesGenetic Predisposition to DiseaseHumansMicroRNAsSchizophreniaTranscription FactorsX-Linked Intellectual DisabilityMicroRNAsTranscription Factors

Identifiers

PMID23439483
OpenAlexW2013726744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.